rotenone has been researched along with Disease Exacerbation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Li, M; Li, Y; Ling, L; Liu, F; Luo, S; Ma, B; Wang, H | 1 |
| Wang, HL; Xiao, G; Xue, J | 1 |
| Arab, A; Chovsepian, A; Drazanova, E; Hadjistyllis, C; Khairnar, A; Pan-Montojo, F; Rektorova, I; Ruda-Kucerova, J; Sejnoha Minsterova, A; Shang, Q; Starcuk, Z; Szabó, N | 1 |
| Fang, Q; Homberg, JR; Li, W; Liao, P; Liu, C; Luan, Y; Meng, X; Shan, L; Shen, J; Swaab, DF; Wang, J; Zhou, P | 1 |
| Horvath, TL; Kim, HJ; Manfredi, G; Peixoto, PM; Sider, B; Starkov, A | 1 |
| Chen, NH; Chu, SF; Li, J; Liu, Y; Song, LK; Sun, JD; Yuan, YH | 1 |
| Deng, H; Li, J; Liu, X; Luo, M; Tang, H; Wang, G | 1 |
| Brenton, J; Cordeiro, MF; Davis, BM; De Groef, L; Guo, L; Malaguarnera, G; Nizari, S; Normando, EM; Pahlitzsch, M; Ravindran, N; Somavarapu, S; Turner, LA | 1 |
| Chan, CS; Guzman, JN; Ilijic, E; Mercer, JN; Meredith, GE; Rick, C; Surmeier, DJ; Tkatch, T | 1 |
9 other study(ies) available for rotenone and Disease Exacerbation
| Article | Year |
|---|---|
Dyclonine relieves the Parkinson's disease progression in rotenone-induced Drosophila model.
Topics: Animals; Disease Progression; Dopaminergic Neurons; Drosophila; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; Rotenone | 2023 |
Transferrin1 modulates rotenone-induced Parkinson's disease through affecting iron homeostasis in Drosophila melanogaster.
Topics: Animals; Brain Injuries; Disease Progression; Drosophila melanogaster; Drosophila Proteins; Head; Homeostasis; Iron; Neurons; Neurotoxins; Oxidative Stress; Parkinson Disease; Phenotype; RNA Interference; Rotenone; Transferrins | 2020 |
Diffusion kurtosis imaging detects the time-dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease.
Topics: Administration, Oral; Animals; Diffusion Tensor Imaging; Disease Progression; Dopaminergic Neurons; Insecticides; Male; Maze Learning; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Rotenone; Time Factors | 2021 |
Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model.
Topics: alpha-Synuclein; Animals; Behavior, Animal; Brain; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopaminergic Neurons; Histamine; Indoles; Inflammation; Male; Microglia; Nerve Degeneration; Parkinson Disease; Parkinsonian Disorders; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Histamine H4; Rotenone | 2019 |
UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antimycin A; Calcium; Disease Progression; Humans; Ion Channels; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; Mutation; Reactive Oxygen Species; Rotenone; Superoxide Dismutase; Superoxide Dismutase-1; Uncoupling Agents; Uncoupling Protein 2 | 2013 |
Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Apomorphine; Body Weight; Brain; Disease Progression; Dopamine; Dopamine Agonists; Enteric Nervous System; Environmental Exposure; Housing, Animal; Male; Mice, Inbred C57BL; Motor Activity; Muscle, Skeletal; Neurons; Olfactory Perception; Parkinsonian Disorders; Rotenone; Tyrosine 3-Monooxygenase | 2015 |
Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway.
Topics: Adenylate Kinase; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chaperonin 60; Disease Progression; Down-Regulation; Electron Transport; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioblastoma; HEK293 Cells; HSP90 Heat-Shock Proteins; Humans; Lipids; Mitochondria; Mitochondrial Proteins; Oxidative Stress; Protein Biosynthesis; Reactive Oxygen Species; RNA, Small Interfering; Rotenone; TOR Serine-Threonine Kinases | 2016 |
The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Topics: Animals; Antiparkinson Agents; Brain; Cell Survival; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Follow-Up Studies; Neuroprotective Agents; Parkinsonian Disorders; PPAR gamma; Rats; Retina; Rosiglitazone; Rotenone; Superior Sagittal Sinus; Thiazolidinediones; Tomography, Optical Coherence | 2016 |
'Rejuvenation' protects neurons in mouse models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Antiparkinson Agents; Calcium; Calcium Channels, L-Type; Dendrites; Disease Models, Animal; Disease Progression; Dopamine; Electric Conductivity; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Mitochondria; Models, Neurological; Neurons; Parkinson Disease; Rotenone; Substantia Nigra | 2007 |